Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
Introduction: Tigecycline and intravenous (i.v.) fosfomycin could be alternative therapeutic options for the treatment of carbapenemase-possessing Enterobacteriaceae bacterial infections. However, routine laboratories are forced to test these drugs using minimum inhibitory concentration (MIC) metho...
Saved in:
| Main Authors: | Fernando Pasteran, Celeste Lucero, Melina Rapoport, Leonor Guerriero, Irene Barreiro, Ezequiel Albornoz, Omar Veliz, Alejandra Corso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2012-02-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/2238 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae: An observational study
by: Jorge Rodríguez-Gómez, et al.
Published: (2025-03-01) -
In vitro susceptibility of OXA-48, NDM, VIM and IMP enzyme- producing Klebsiella spp. and Escherichia coli to fosfomycin
by: Selay Demirci-Duarte, et al.
Published: (2020-04-01) -
Detection of the novel IMP-38 among carbapenemase-producing Enterobacteriaceae in a university hospital, China
by: Zijuan Jian, et al.
Published: (2014-08-01) -
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01) -
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections
by: Ayhanim Tumturk, et al.
Published: (2019-01-01)